The Diabetic Kidney

Although diabetic kidney disease is the most prevalent cause of end-stage renal disease and the disease most often leading to chronic renal replacement therapy and kidney transplantation, there has been, in recent years, a steady increase in basic and clinical knowledge of the problem. In The Diabet...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Cortes, Pedro. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2006.
Edition:1st ed. 2006.
Series:Contemporary Diabetes,
Subjects:
Online Access:https://doi.org/10.1007/978-1-59745-153-6
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Basic Pathophysiology and Biochemistry of Diabetic Nephropathy
  • Angiotensin II and Its Receptors in the Pathogenesis of Diabetic Nephropathy
  • Altered Renal Microvascular Function in Early Diabetes
  • Proteinuria and Interstitial Fibrogenesis in Diabetic Nephropathy
  • Podocytes and Diabetic Nephropathy
  • Altered Glucose Transport and Its Metabolic Effects in Glomerular Cells
  • mRNA Translation in Diabetic Nephropathy
  • The Hexosamine Biosynthesis Pathway
  • Glycation
  • Oxidative and Glycooxidative Stress in Diabetic Nephropathy
  • Connective Tissue Growth Factor in the Pathogenesis of Diabetic Nephropathy
  • Vascular Endothelial Growth Factor as a Determinant of Diabetic Nephropathy
  • Transforming Growth Factor-? Signal Transduction in the Pathogenesis of Diabetic Nephropathy
  • Hepatocyte Growth Factor
  • Proteomics in the Investigation of Diabetic Nephropathy
  • Gene Expression Profiling in the Investigation of Diabetic Nephropathy
  • PPAR-? Ligands and Diabetic Nephropathy
  • ?-Endosulfine in Diabetic Nephropathy
  • The Prospect of a Novel Therapeutic, Bone Morphogenetic Protein-7, in Diabetic Nephropathy
  • Clinical Aspects of Diabetic Nephropathy
  • Genetic Determinants of Diabetic Nephropathy in Type 2 Diabetes
  • Major Risks Indicators for Diabetic Kidney Disease
  • The Structure of Human Diabetic Nephropathy
  • Diabetic Kidney Disease in Transitional and Disadvantaged Populations
  • Screening and Treatment of Early Diabetic Renal Disease in Type 1 and Type 2 Diabetes
  • Treatment in Advanced Renal Disease in Type 1 and Type 2 Diabetes
  • Diabetic Renal and Related Heart Disease
  • Management of Diabetic End-Stage Renal Disease With Dialysis
  • Diabetic Retinopathy and Nephropathy
  • Hypertension and Cardiovascular Disease
  • Endothelial Dysfunction
  • Anemia and Diabetic Nephropathy.